ALT 0 3 0 3 B-clinical_variable
, 3 4 3 4 O
AST 5 8 5 8 B-clinical_variable
and 9 12 9 12 O
Alkaline 13 21 13 21 B-clinical_variable
Phosphatase 22 33 22 33 I-clinical_variable
≤ 34 35 34 35 O
2.5 36 39 36 39 B-upper_bound
times 40 45 40 45 I-upper_bound
the 46 49 46 49 I-upper_bound
upper 50 55 50 55 I-upper_bound
limit 56 61 56 61 I-upper_bound
of 62 64 62 64 I-upper_bound
normal 65 71 65 71 I-upper_bound

Absolute 0 8 72 80 B-clinical_variable
lymphocyte 9 19 81 91 I-clinical_variable
count 20 25 92 97 I-clinical_variable
≥ 26 27 98 99 O
500 28 31 100 103 B-lower_bound
/ 31 32 103 104 I-lower_bound
mcl 32 35 104 107 I-lower_bound
and 36 39 108 111 O
absolute 40 48 112 120 B-clinical_variable
neutrophil 49 59 121 131 I-clinical_variable
count 60 65 132 137 I-clinical_variable
≥ 66 67 138 139 O
500 68 71 140 143 O
/ 71 72 143 144 O
mcl 72 75 144 147 O

Diagnosis 0 9 148 157 O
of 10 12 158 160 O
neuroblastoma 13 26 161 174 B-cancer
( 27 28 175 176 I-cancer
NB 28 30 176 178 I-cancer
) 30 31 178 179 I-cancer
as 32 34 180 182 O
defined 35 42 183 190 O
by 43 45 191 193 O
international 46 59 194 207 O
criteria 60 68 208 216 O

High 0 4 217 221 B-cancer
- 4 5 221 222 I-cancer
risk 5 9 222 226 I-cancer
NB 10 12 227 229 I-cancer
( 13 14 230 231 O
as 14 16 231 233 O
defined 17 24 234 241 O
above 25 30 242 247 O
) 30 31 247 248 O
and 32 35 249 252 O
in 36 38 253 255 O
1 39 40 256 257 O
) 40 41 257 258 O
first 42 47 259 264 O
CR 48 50 265 267 B-clinical_variable
at 51 53 268 270 O
6 54 55 271 272 B-lower_bound
≥ 56 57 273 274 O
months 58 64 275 281 O
from 65 69 282 286 O
initiation 70 80 287 297 O
of 81 83 298 300 O
immunotherapy 84 97 301 314 B-treatment
using 98 103 315 320 O
anti 104 108 321 325 B-treatment
- 108 109 325 326 I-treatment
GD2 109 112 326 329 I-treatment
antibody 113 121 330 338 I-treatment
, 121 122 338 339 O
or 123 125 340 342 O
2 126 127 343 344 O
) 127 128 344 345 O
second 129 135 346 352 O
or 136 138 353 355 O
subsequent 139 149 356 366 O
remission 150 159 367 376 O

History 0 7 377 384 O
of 8 10 385 387 O
allergy 11 18 388 395 O
to 19 21 396 398 O
KLH 22 25 399 402 B-allergy_name
, 25 26 402 403 O
QS-21 27 32 404 409 B-allergy_name
, 32 33 409 410 O
OPT-821 34 41 411 418 B-allergy_name
, 41 42 418 419 O
or 43 45 420 422 O
glucan 46 52 423 429 B-allergy_name

Patients 0 8 430 438 O
with 9 13 439 443 O
grade 14 19 444 449 B-upper_bound
3 20 21 450 451 I-upper_bound
toxicities 22 32 452 462 I-upper_bound
or 33 35 463 465 O
less 36 40 466 470 O
using 41 46 471 476 O
the 47 50 477 480 O
Common 51 57 481 487 O
Toxicity 58 66 488 496 O
Criteria 67 75 497 505 O
( 76 77 506 507 O
Version 77 84 507 514 O
3.0 85 88 515 518 O
) 88 89 518 519 O
developed 90 99 520 529 O
by 100 102 530 532 O
the 103 106 533 536 O
National 107 115 537 545 O
Cancer 116 122 546 552 O
Institute 123 132 553 562 O
of 133 135 563 565 O
the 136 139 566 569 O
USA 140 143 570 573 O
( 144 145 574 575 O
CTCAE 145 150 575 580 O
v3.0 151 155 581 585 O
) 155 156 585 586 O
related 157 164 587 594 O
to 165 167 595 597 O
cardiac 168 175 598 605 O
, 175 176 605 606 O
neurological 177 189 607 619 O
, 189 190 619 620 O
pulmonary 191 200 621 630 O
, 200 201 630 631 O
renal 202 207 632 637 O
, 207 208 637 638 O
hepatic 209 216 639 646 O
or 217 219 647 649 O
gastrointestinal 220 236 650 666 O
function 237 245 667 675 O
as 246 248 676 678 O
determined 249 259 679 689 O
by 260 262 690 692 O
blood 263 268 693 698 O
tests 269 274 699 704 O
or 275 277 705 707 O
physical 278 286 708 716 O
exam 287 291 717 721 O

Prior 0 5 722 727 B-treatment
treatment 6 15 728 737 I-treatment
with 16 20 738 742 O
other 21 26 743 748 O
immunotherapy 27 40 749 762 B-treatment
, 40 41 762 763 O
including 42 51 764 773 O
antibodies 52 62 774 784 B-treatment
, 62 63 784 785 O
is 64 66 786 788 O
allowed 67 74 789 796 O

bone 0 4 797 801 B-chronic_disease
marrow 5 11 802 808 I-chronic_disease
metastases 12 22 809 819 I-chronic_disease
plus 23 27 820 824 O
high 28 32 825 829 O
urine 33 38 830 835 B-clinical_variable
catecholamine 39 52 836 849 I-clinical_variable
levels 53 59 850 856 I-clinical_variable

stage 0 5 857 862 O
4 6 7 863 864 O
with 8 12 865 869 O
( 13 14 870 871 O
any 14 17 871 874 O
age 18 21 875 878 O
) 21 22 878 879 O
or 23 25 880 882 O
without 26 33 883 890 O
( 34 35 891 892 O
> 35 36 892 893 O
18 36 38 893 895 B-lower_bound
months 39 45 896 902 I-lower_bound
old 46 49 903 906 O
) 49 50 906 907 O
MYCN 51 55 908 912 O
amplification 56 69 913 926 O
, 69 70 926 927 O
MYCN 71 75 928 932 O
- 75 76 932 933 O
amplified 76 85 933 942 O
stage 86 91 943 948 O
3 92 93 949 950 O
( 94 95 951 952 O
unresectable 95 107 952 964 O
; 107 108 964 965 O
any 109 112 966 969 O
age 113 116 970 973 O
) 116 117 973 974 O
, 117 118 974 975 O
MYCN 119 123 976 980 O
- 123 124 980 981 O
amplified 124 133 981 990 O
stage 134 139 991 996 O
4S 140 142 997 999 O
, 142 143 999 1000 O
or 144 146 1001 1003 O
disease 147 154 1004 1011 O
resistant 155 164 1012 1021 O
to 165 167 1022 1024 O
standard 168 176 1025 1033 O
chemotherapy 177 189 1034 1046 B-treatment

≥ 0 1 1047 1048 O
3 2 3 1049 1050 B-lower_bound
weeks 4 9 1051 1056 I-lower_bound
between 10 17 1057 1064 O
completion 18 28 1065 1075 O
of 29 31 1076 1078 O
chemotherapy 32 44 1079 1091 B-treatment
or 45 47 1092 1094 O
immunotherapy 48 61 1095 1108 B-treatment
and 62 65 1109 1112 O
1st 66 69 1113 1116 B-treatment
vaccination 70 81 1117 1128 I-treatment

